- Home
- PBYI vs BOOM Comparison
PBYI vs BOOM Comparison
Compare PBYI & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BOOM
- Stock Information
- Founded
- PBYI 2010
- BOOM 1965
- Country
- PBYI United States
- BOOM United States
- Employees
- PBYI N/A
- BOOM N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BOOM Industrial Specialties
- Sector
- PBYI Health Care
- BOOM Industrials
- Exchange
- PBYI Nasdaq
- BOOM Nasdaq
- Market Cap
- PBYI 154.1M
- BOOM 167.0M
- IPO Year
- PBYI N/A
- BOOM N/A
- Fundamental
- Price
- PBYI $3.14
- BOOM $8.39
- Analyst Decision
- PBYI Strong Buy
- BOOM Buy
- Analyst Count
- PBYI 1
- BOOM 2
- Target Price
- PBYI $7.00
- BOOM $16.75
- AVG Volume (30 Days)
- PBYI 418.2K
- BOOM 171.0K
- Earning Date
- PBYI 05-01-2025
- BOOM 05-01-2025
- Dividend Yield
- PBYI N/A
- BOOM N/A
- EPS Growth
- PBYI 37.78
- BOOM N/A
- EPS
- PBYI 0.62
- BOOM N/A
- Revenue
- PBYI $230,468,000.00
- BOOM $642,851,000.00
- Revenue This Year
- PBYI N/A
- BOOM $0.03
- Revenue Next Year
- PBYI $3.27
- BOOM $5.50
- P/E Ratio
- PBYI $5.06
- BOOM N/A
- Revenue Growth
- PBYI N/A
- BOOM N/A
- 52 Week Low
- PBYI $2.23
- BOOM $6.65
- 52 Week High
- PBYI $6.06
- BOOM $19.72
- Technical
- Relative Strength Index (RSI)
- PBYI 45.33
- BOOM 48.60
- Support Level
- PBYI $3.14
- BOOM $8.76
- Resistance Level
- PBYI $3.56
- BOOM $9.20
- Average True Range (ATR)
- PBYI 0.19
- BOOM 0.39
- MACD
- PBYI -0.05
- BOOM 0.03
- Stochastic Oscillator
- PBYI 17.54
- BOOM 44.90
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BOOM DMC Global Inc.
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.